Skip to main content
Erschienen in: Archives of Osteoporosis 1/2015

01.12.2015 | Original Article

Swedish osteoporosis care

verfasst von: Emma Jonsson, Daniel Eriksson, Kristina Åkesson, Östen Ljunggren, Stina Salomonsson, Fredrik Borgström, Oskar Ström

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Summary

Mini-abstract

The objective of this study was to review and describe the current state of Swedish osteoporosis care and to highlight ongoing challenges. This report encompasses quantitative health outcomes based on Swedish registry data as well as organizational and management aspects.

Executive summary

Swedish osteoporosis care is characterized by a significant burden of disease, difficulties in identifying high-risk patients, and fragmented pathways for patients in need of secondary fracture prevention. This report aimed to describe the current state, gaps, and challenges in Swedish osteoporosis care, using Swedish national databases, questionnaires, and interviews with healthcare representatives. A secondary aim was to develop quality and process measures to compare differences between counties and to use those measures to describe the interaction between quantitative health outcomes and aspects of care organization and management. In conjunction with fractures, a considerably smaller proportion of men are treated than women, and a smaller proportion of older women are treated compared to younger groups. Between 3 and 16 % of patients receive treatment after a fracture, and the treatment rate in this patient group can likely increase. In addition to an unsatisfactory treatment rate, a limited number of those treated continue treatment throughout the recommended treatment durations, leading to increased risk of fracture. With a substantial variation between counties, there is a clear difficulty to identify non-persistent patients and switch to an alternative treatment. Collaboration around the patient across specialties has been lacking, and systems for secondary prevention have been concentrated to a few counties. However, when this study was conducted, there was a general trend towards implementing regional care programs. This report suggests possible strategies for improving quality of care and, hopefully, it can provide a basis for future evaluations and regional improvement of osteoporosis care in Sweden and other countries.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
This report defines major osteoporotic fracture in the same way as in Quality and Efficiency in Swedish Healthcare; ICD-10 S32.1-8, S52.5-6, S42.2-3, S72.0-4, S22.x, S82.1.
 
2
Only patients with a first care occasion in inpatient care for any of the defined diagnosis codes are included.
 
3
For example, in the report “Unequal conditions for health and healthcare” [Ojämna villkor för hälsa och vård: Jämlikhetsperspektiv på hälso- och sjukvården”], the National Board of Health and Welfare reports challenges in certain healthcare areas where national guidelines are in place [59].
 
Literatur
1.
Zurück zum Zitat Giangregorio L et al (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35(5):293–305PubMedCrossRef Giangregorio L et al (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35(5):293–305PubMedCrossRef
2.
Zurück zum Zitat SKL och Socialstyrelsen (2012) Öppna Jämförelser av hälso- och sjukvårdens kvalitet och effektivitet SKL och Socialstyrelsen (2012) Öppna Jämförelser av hälso- och sjukvårdens kvalitet och effektivitet
3.
Zurück zum Zitat Strom O et al (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6(1-2):59–155PubMedCrossRef Strom O et al (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6(1-2):59–155PubMedCrossRef
5.
Zurück zum Zitat Elliot-Gibson V et al (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15(10):767–78PubMedCrossRef Elliot-Gibson V et al (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15(10):767–78PubMedCrossRef
6.
Zurück zum Zitat SKL och Socialstyrelsen (2013) Öppna Jämförelser 2013-Läkemedelsbehandlingar-Jämförelser mellan landsting SKL och Socialstyrelsen (2013) Öppna Jämförelser 2013-Läkemedelsbehandlingar-Jämförelser mellan landsting
7.
Zurück zum Zitat SBU (2003) Osteoporos—prevention, diagnostik och behandling. (165/1, 165/2) SBU (2003) Osteoporos—prevention, diagnostik och behandling. (165/1, 165/2)
8.
Zurück zum Zitat Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4(6):368–81PubMedCrossRef Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4(6):368–81PubMedCrossRef
9.
Zurück zum Zitat Melton LJ 3rd (2001) The prevalence of osteoporosis: gender and racial comparison. Calcif Tissue Int 69(4):179–81PubMedCrossRef Melton LJ 3rd (2001) The prevalence of osteoporosis: gender and racial comparison. Calcif Tissue Int 69(4):179–81PubMedCrossRef
10.
Zurück zum Zitat Kanis JA et al (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27(5):585–90PubMedCrossRef Kanis JA et al (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27(5):585–90PubMedCrossRef
11.
Zurück zum Zitat Statistiska Centralbyrån (SCB). 2014-02-21. Statistiska Centralbyrån (SCB). 2014-02-21.
12.
Zurück zum Zitat Olszynski WP et al (2004) Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin Ther 26(1):15–28PubMedCrossRef Olszynski WP et al (2004) Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin Ther 26(1):15–28PubMedCrossRef
13.
Zurück zum Zitat Cooper C et al (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7(2):221–7PubMedCrossRef Cooper C et al (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7(2):221–7PubMedCrossRef
14.
Zurück zum Zitat Hasserius R et al (2005) Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly—a 12- and 22-year follow-up of 257 patients. Calcif Tissue Int 76(4):235–42PubMedCrossRef Hasserius R et al (2005) Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly—a 12- and 22-year follow-up of 257 patients. Calcif Tissue Int 76(4):235–42PubMedCrossRef
15.
Zurück zum Zitat Barrett JA, Baron JA, Beach ML (2003) Mortality and pulmonary embolism after fracture in the elderly. Osteoporos Int 14(11):889–94PubMedCrossRef Barrett JA, Baron JA, Beach ML (2003) Mortality and pulmonary embolism after fracture in the elderly. Osteoporos Int 14(11):889–94PubMedCrossRef
16.
Zurück zum Zitat Jonsson B et al (2011) Cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int 22(3):967–82PubMedCrossRef Jonsson B et al (2011) Cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int 22(3):967–82PubMedCrossRef
17.
Zurück zum Zitat Jalava T et al (2003) Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Miner Res 18(7):1254–60PubMedCrossRef Jalava T et al (2003) Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Miner Res 18(7):1254–60PubMedCrossRef
18.
19.
Zurück zum Zitat Borgstrom F et al (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17(5):637–50PubMedCrossRef Borgstrom F et al (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17(5):637–50PubMedCrossRef
20.
Zurück zum Zitat Marsh D et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22(7):2051–65PubMedCrossRef Marsh D et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22(7):2051–65PubMedCrossRef
21.
Zurück zum Zitat Gillespie LD et al (2012) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 9:CD007146PubMed Gillespie LD et al (2012) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 9:CD007146PubMed
23.
Zurück zum Zitat Socialstyrelsen (2012) Nationella riktlinjer för rörelseorganens sjukdomar Socialstyrelsen (2012) Nationella riktlinjer för rörelseorganens sjukdomar
24.
Zurück zum Zitat Marie PJ (2006) Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation. Curr Opin Rheumatol 18(Suppl 1):S11–5PubMedCrossRef Marie PJ (2006) Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation. Curr Opin Rheumatol 18(Suppl 1):S11–5PubMedCrossRef
26.
Zurück zum Zitat SKL och Socialstyrelsen (2013) Öppna Jämförelser av hälso- och sjukvårdens kvalitet och effektivitet SKL och Socialstyrelsen (2013) Öppna Jämförelser av hälso- och sjukvårdens kvalitet och effektivitet
27.
Zurück zum Zitat McLellan AR et al (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22(7):2083–98PubMedCrossRef McLellan AR et al (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22(7):2083–98PubMedCrossRef
28.
Zurück zum Zitat Kanis JA, WHO Scientific Group Technical Report (2007) Assessment of osteoporosis at the primary health care level: University of Sheffield Kanis JA, WHO Scientific Group Technical Report (2007) Assessment of osteoporosis at the primary health care level: University of Sheffield
29.
Zurück zum Zitat Strom O et al (2010) FRAX and its applications in health economics—cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example. Bone 47(2):430–7PubMedCrossRef Strom O et al (2010) FRAX and its applications in health economics—cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example. Bone 47(2):430–7PubMedCrossRef
30.
Zurück zum Zitat Kanis JA, Reginster JY (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women—what is the current message for clinical practice? Pol Arch Med Wewn 118(10):538–40PubMed Kanis JA, Reginster JY (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women—what is the current message for clinical practice? Pol Arch Med Wewn 118(10):538–40PubMed
31.
Zurück zum Zitat Hernlund E et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1-2):136PubMedPubMedCentralCrossRef Hernlund E et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1-2):136PubMedPubMedCentralCrossRef
32.
34.
Zurück zum Zitat Pye SR et al (2003) Frequency and causes of osteoporosis in men. Rheumatology (Oxford) 42(6):811–2CrossRef Pye SR et al (2003) Frequency and causes of osteoporosis in men. Rheumatology (Oxford) 42(6):811–2CrossRef
35.
Zurück zum Zitat Geusens P et al (2008) Impact of systematic implementation of a clinical case finding strategy on diagnosis and therapy of postmenopausal osteoporosis. J Bone Miner Res 23(6):812–8PubMedCrossRef Geusens P et al (2008) Impact of systematic implementation of a clinical case finding strategy on diagnosis and therapy of postmenopausal osteoporosis. J Bone Miner Res 23(6):812–8PubMedCrossRef
36.
Zurück zum Zitat Kanis JA et al (2009) How to decide who to treat. Best Pract Res Clin Rheumatol 23(6):711–26PubMedCrossRef Kanis JA et al (2009) How to decide who to treat. Best Pract Res Clin Rheumatol 23(6):711–26PubMedCrossRef
37.
Zurück zum Zitat SKL och Socialstyrelsen (2011) Öppna Jämförelser av hälso- och sjukvårdens kvalitet och effektivitet SKL och Socialstyrelsen (2011) Öppna Jämförelser av hälso- och sjukvårdens kvalitet och effektivitet
38.
Zurück zum Zitat Ettinger B, Chidambaran P, Pressman A (2001) Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs. Am J Manag Care 7(6):597–605PubMed Ettinger B, Chidambaran P, Pressman A (2001) Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs. Am J Manag Care 7(6):597–605PubMed
39.
40.
Zurück zum Zitat Feldstein AC et al (2008) Harnessing stakeholder perspectives to improve the care of osteoporosis after a fracture. Osteoporos Int 19(11):1527–40PubMedCrossRef Feldstein AC et al (2008) Harnessing stakeholder perspectives to improve the care of osteoporosis after a fracture. Osteoporos Int 19(11):1527–40PubMedCrossRef
42.
Zurück zum Zitat Majumdar SR et al (2009) Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med 169(1):25–31PubMedCrossRef Majumdar SR et al (2009) Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med 169(1):25–31PubMedCrossRef
43.
Zurück zum Zitat Sander B et al (2008) A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 90(6):1197–205PubMedCrossRef Sander B et al (2008) A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 90(6):1197–205PubMedCrossRef
44.
45.
Zurück zum Zitat Kanis JA et al (2012) FRAX((R)) with and without bone mineral density. Calcif Tissue Int 90(1):1–13PubMedCrossRef Kanis JA et al (2012) FRAX((R)) with and without bone mineral density. Calcif Tissue Int 90(1):1–13PubMedCrossRef
46.
Zurück zum Zitat Klotzbuecher CM et al (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721–39PubMedCrossRef Klotzbuecher CM et al (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721–39PubMedCrossRef
47.
Zurück zum Zitat Kanis JA et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19(6):893–9PubMedCrossRef Kanis JA et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19(6):893–9PubMedCrossRef
48.
Zurück zum Zitat Strom O et al (2010) Cost-effectiveness of balloon kyphoplasty in patients with symptomatic vertebral compression fractures in a UK setting. Osteoporos Int 21(9):1599–608PubMedCrossRef Strom O et al (2010) Cost-effectiveness of balloon kyphoplasty in patients with symptomatic vertebral compression fractures in a UK setting. Osteoporos Int 21(9):1599–608PubMedCrossRef
49.
Zurück zum Zitat Socialstyrelsen (2012) Nationella riktlinjer för rörelseorganens sjukdomar- Vetenskapligt underlag Socialstyrelsen (2012) Nationella riktlinjer för rörelseorganens sjukdomar- Vetenskapligt underlag
50.
Zurück zum Zitat Johnell O et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15(3):175–9PubMedCrossRef Johnell O et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15(3):175–9PubMedCrossRef
51.
Zurück zum Zitat Boonen S et al (2012) Postmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long-term continuation on bone turnover and fracture risk—a perspective. J Bone Miner Res 27(5):963–74PubMedCrossRef Boonen S et al (2012) Postmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long-term continuation on bone turnover and fracture risk—a perspective. J Bone Miner Res 27(5):963–74PubMedCrossRef
52.
Zurück zum Zitat De Geest S, Sabate E (2003) Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2(4):323PubMedCrossRef De Geest S, Sabate E (2003) Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2(4):323PubMedCrossRef
53.
Zurück zum Zitat Haynes RB, McDonald HP, Garg AX (2002) Helping patients follow prescribed treatment: clinical applications. JAMA 288(22):2880–3PubMedCrossRef Haynes RB, McDonald HP, Garg AX (2002) Helping patients follow prescribed treatment: clinical applications. JAMA 288(22):2880–3PubMedCrossRef
54.
Zurück zum Zitat Landfeldt E et al (2012) Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA). Osteoporos Int 23(2):433–43PubMedCrossRef Landfeldt E et al (2012) Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA). Osteoporos Int 23(2):433–43PubMedCrossRef
55.
Zurück zum Zitat Silverman SL, Gold DT (2008) Compliance and persistence with osteoporosis therapies. Curr Rheumatol Rep 10(2):118–22PubMedCrossRef Silverman SL, Gold DT (2008) Compliance and persistence with osteoporosis therapies. Curr Rheumatol Rep 10(2):118–22PubMedCrossRef
56.
Zurück zum Zitat Landfeldt E, Lundkvist J, Strom O (2011) The societal burden of poor persistence to treatment of osteoporosis in Sweden. Bone 48(2):380–8PubMedCrossRef Landfeldt E, Lundkvist J, Strom O (2011) The societal burden of poor persistence to treatment of osteoporosis in Sweden. Bone 48(2):380–8PubMedCrossRef
57.
58.
Zurück zum Zitat Gleeson T et al (2009) Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int 20(12):2127–34PubMedPubMedCentralCrossRef Gleeson T et al (2009) Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int 20(12):2127–34PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Socialstyrelsen och SKL (2009) Mot en effektivare kunskapsstyrning. Kartläggning och analys av nationellt och regionalt stöd före en evidensbaserad praktik i hälso- och sjukvården Socialstyrelsen och SKL (2009) Mot en effektivare kunskapsstyrning. Kartläggning och analys av nationellt och regionalt stöd före en evidensbaserad praktik i hälso- och sjukvården
61.
Zurück zum Zitat Fernler K (2012) Kunskapsstyrning för ledning och policyarbete Fernler K (2012) Kunskapsstyrning för ledning och policyarbete
Metadaten
Titel
Swedish osteoporosis care
verfasst von
Emma Jonsson
Daniel Eriksson
Kristina Åkesson
Östen Ljunggren
Stina Salomonsson
Fredrik Borgström
Oskar Ström
Publikationsdatum
01.12.2015
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2015
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-015-0222-7

Weitere Artikel der Ausgabe 1/2015

Archives of Osteoporosis 1/2015 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.